Advanced search
Publication Cover
Journal of Inflammation Research Volume 15, 2022 - Issue
Submit an article Journal homepage
175
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai–Dorfman Disease

Ming Tang1 Department of Pathology, the First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, People’s Republic of ChinaView further author information
,
Xue-Zhong Gu2 Department of Hematology, the First People's Hospital of Yunnan Province, Yunnan Blood Disease Clinical Medical Research Center, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, People’s Republic of ChinaView further author information
,
Peng-Chun Wu3 Department of Pathology, Kunming Kingmed Institute for Clinical Laboratory, Kunming, 650506, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Xuan-Tao Yang1 Department of Pathology, the First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 2775-2787 | Published online: 29 Apr 2022

References

  • Garces S, Medeiros LJ, Patel KP, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease. Mod Pathol. 2017;30(10):1367–1377. doi:10.1038/modpathol.2017.55
  • Goyal G, Ravindran A, Young JR, et al. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica. 2020;105(2):348–357.
  • Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131(26):2877–2890.
  • Al-Khateeb TH. Cutaneous Rosai-Dorfman Disease of the Face: a Comprehensive Literature Review and Case Report. J Oral Maxillofac Surg. 2016;74(3):528–540.
  • Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87(1):63–70.
  • Olmedo-Reneaum A, Molina-Jaimes A, Conde-Vazquez E, Montero-Vazquez S. Rosai-Dorfman disease and superinfection due to Salmonella enterica and Mycobacterium avium complex in a patient living with HIV. IDCases. 2020;19:e00698.
  • Gorodetskiy VR, Klapper W, Probatova NA, Vasilyev VI, Rozhnova EV. Simultaneous Occurrence of Rosai-Dorfman Disease and Nodal Marginal Zone Lymphoma in a Patient with Sjögren’s Syndrome. Case Rep Hematol. 2018;2018:7930823.
  • Tracht J, Reid MD, Xue Y, et al. Rosai-Dorfman Disease of the Pancreas Shows Significant Histologic Overlap With IgG4-related Disease. Am J Surg Pathol. 2019;43(11):1536–1546.
  • Chen LYC, Slack GW, Carruthers MN. IgG4-related disease and Rosai-Dorfman-Destombes disease. Lancet. 2021;398(10307):1213–1214.
  • Liu L, Perry AM, Cao W, et al. Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol. 2013;140(3):395–402.
  • Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J. BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv. 2019;3(12):1848–1853.
  • Richardson TE, Wachsmann M, Oliver D, et al. BRAF mutation leading to central nervous system Rosai-Dorfman disease. Ann Neurol. 2018;84(1):147–152.
  • Jafri ZA, Reddy SP, Cassarino DS. KRAS 117N positive Rosai-Dorfman disease with atypical features. J Cutan Pathol. 2021;48(1):147–150.
  • Wu KJ, Li SH, Liao JB, et al. Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: a Pilot Study. Biology. 2021;10(5):396.
  • Dalia S, Sagatys E, Sokol L, Kubal T. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21(4):322–327.
  • Pulsoni A, Anghel G, Falcucci P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69(1):67–71.
  • Pagel JM, Lionberger J, Gopal AK, Sabath DE, Loeb K. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol. 2007;82(12):1121–1122.
  • Jacobsen E, Shanmugam V, Jagannathan J. Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib. N Engl J Med. 2017;377(24):2398–2399.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.